Patent · US Active

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

US11236158B2 · kind B2 · utility

2Cited by

15References

6Claims

0Family size

Assignee

SWEDISH ORPHAN BIOVITRUM AG · SE

Inventors

Cristina DE MIN · Geneva, CH
Walter Ferlin · Annemasse, FR
Fabrizio De Benedetti · Geneva, CH

Key dates

Filing date	Mar 26, 2020
Grant date	Feb 1, 2022
Priority date	—
Expiry date	Mar 26, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates generally to methods compositions and dosing regimens for treating, preventing and/or delaying the onset or progression of, or alleviating a symptom associated with elevated IFN-γ levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.